Updates are available Correction dated 2025-10-21
Click to view Correction: https://doi.org/10.1007/s11606-025-09948-y
-
Authors
McElfish, Pearl A. https://orcid.org/0000-0002-4033-6241
Selig, James P.
Scott, Aaron J.
Rowland, Brett
Willis, Don E.
Reece, Sharon
CarlLee, Sheena
Macechko, Michael D.
Shah, Sumit K.
-
Funding
Funding for this research was provided by:
Office of Minority Health of the U.S. Department of Health and Human Services (1 CPIMP211231-01-00)
Reach Out and Connect (ROaC) Program Supplemental funds for Immunization Outreach (6 NU58DP006595-03-01)
National Center for Advancing Translational Sciences (UL1 TR003107)
Rapid Acceleration of Diagnostics (NIH 3 R01MD013852-02S3)
Rapid Acceleration of Diagnostics (NIH 3 R01MD013852-03S2)
Community Engagement Alliance (CEAL) Against COVID-19 Disparities (NIH 10T2HL156812-01)
- License Information
-
More Information
Article History
Received: 15 February 2022
Accepted: 21 October 2022
First Online: 2 November 2022
Change Date: 21 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11606-025-09948-y
Declarations
:
: Dr. Sheena CarlLee reports owning Pfizer stock. The authors declared no other potential conflicts of interest.
